CMAJ • August 15, 2006; 175 (4). doi:10.1503/cmaj.060108.
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuyuki, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuyuki, R. T.
Related Collections
Right arrow Vascular surgery
Right arrow Heart failure
Right arrowRelated Article


Research

Revascularization in patients with heart failure

Ross T. Tsuyuki, Fiona M. Shrive, P. Diane Galbraith, Merril L. Knudtson, Michelle M. Graham for the APPROACH Investigators

From the Division of Cardiology, University of Alberta (Tsuyuki, Graham), Edmonton, and University of Calgary (Shrive, Galbraith, Knudtson), Calgary, Alta.

Correspondence to: Dr. Michelle M. Graham, Division of Cardiology, 2C2 Walter Mackenzie Centre, University of Alberta Hospital, 8440–112 St., Edmonton AB T6G 2B7; mmgraham{at}cha.ab.ca

Background: Although practice guidelines recommend coronary revascularization for patients with heart failure, the evidence to support this recommendation is weak. The objective of our study was to determine the association of coronary revascularization with survival in patients who have had heart failure.

Methods: Data were obtained from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH), a clinical outcome–monitoring initiative that has captured data on all patients undergoing cardiac catheterization in the province of Alberta since 1995. Our study included data from patients with a history of heart failure and with documented coronary artery disease; patients with normal coronary arteries or prior coronary artery bypass grafting (CABG) were excluded. We constructed survival curves and adjusted them by the corrected group prognosis method (incorporating all clinical variables in APPROACH). Propensity scores were used to account for clinical characteristics that could influence the decision to revascularize.

Results: A total of 2538 patients (mean age 68 yr, standard deviation [SD] 11 yr, 31% female) underwent revascularization; 1690 patients (mean age 69 [SD 11] yr, 34% female) did not. Crude 1-year mortality was 11.8% among patients who underwent revascularization, compared with 21.6% among those who did not. Adjusted survival curves diverged early and continued up to 7 years of follow-up (hazard ratio 0.50, 95% confidence interval 0.44–0.57). Propensity scores showed improved survival with revascularization across all quintiles of likelihood of revascularization.

Interpretation: This new evidence lends support to practice guidelines, which recommend revascularization in patients with heart failure and coronary disease.



Related Article

To revascularize or not to revascularize: a dilemma in heart failure
Roxy Senior
Can. Med. Assoc. J. 2006 175: 372. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur J Heart FailHome page
J. S. Rossi, J. D. Flaherty, G. C. Fonarow, E. Nunez, W. Gattis Stough, W. T. Abraham, N. M. Albert, B. H. Greenberg, C. M. O'Connor, C. W. Yancy, et al.
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)
Eur J Heart Fail, December 1, 2008; 10(12): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
C. van Walraven and A. J. Forster
Bias in revascularization study
Can. Med. Assoc. J., April 10, 2007; 176(8): 1125 - 1125.
[Full Text] [PDF]


Home page
CMAJHome page
F. M. Shrive and R. T. Tsuyuki
Bias in revascularization study
Can. Med. Assoc. J., April 10, 2007; 176(8): 1125 - 1125.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. G. Ray, C. M. Norris, J. A. Udell, R. T. Tsuyuki, F. A. McAlister, M. L. Knudtson, and W. A. Ghali
Lipid-Lowering Therapy and Outcomes in Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 27 - 35.
[Abstract] [PDF]


Home page
CMAJHome page
R. Senior
To revascularize or not to revascularize: a dilemma in heart failure.
Can. Med. Assoc. J., August 15, 2006; 175(4): 372 - 372.
[Full Text] [PDF]

eLetters:

Read all eLetters

Time-dependent bias
Carl van Walraven
CMAJ, 22 Aug 2006 [Full text]